Authors


Tyler Wood, PharmD, BCBBS

Latest:

Managing Treatment With New and Expensive Drugs: What Pharmacy Leaders Need to Know

With the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.


Rebecca F. Renier

Latest:

California Modifies End of Life Option Act

Amendments reflecting more contemporary options could raise ethical questions for health care workers.


Lauren Bronson

Latest:

August 2021 Interactive Case Studies

How would you answer these patients' questions?


Melinda Cook, PharmD, BCOP

Latest:

New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab

Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.


Emily Longaker, PharmD, BCPS

Latest:

Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 Diabetes

Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.


Ashish Jain, MS, BScPharm

Latest:

The Evolving Role of Pharmacovigilance in Digital Therapeutics

Digital therapeutics (DTx), a novel evidence-based software approach, is revolutionizing health care by delivering personalized treatments. Pharmacovigilance ensures DTx safety but faces challenges such as data privacy and standardization.


Cooper Bailey, PharmD

Latest:

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

The program develops patient-centered oncology pharmacists through comprehensive training.